Course Code: BP102T
Unit V Overview
Unit V: Semisolid Dosage Forms. This unit explains how bases, dispersed ingredients and preparation methods determine the performance of ointments, pastes, creams and gels. It also covers suppositories and pessaries: solid dosage units that soften, melt or dissolve after administration.
Topics Covered – Syllabus Coverage
| Required topic | Coverage |
|---|---|
| Semisolids: definitions, classification, advantages and disadvantages | Sections 5.1-5.2 |
| Ointment bases: classification, properties and selection | Sections 5.3-5.6 |
| Other excipients used in semisolids | Section 5.7 |
| General preparation of ointments | Sections 5.8-5.10 |
| General preparation of pastes | Section 5.11 |
| General preparation of creams | Section 5.12 |
| General preparation of gels | Section 5.13 |
| Semisolid quality, comparison and calculations | Sections 5.14-5.15 |
| Suppositories / pessaries: definition, types, advantages and disadvantages | Sections 5.16-5.17 |
| Ideal suppository bases, base types and excipients | Sections 5.18-5.21 |
| Mould calibration and displacement value | Sections 5.22-5.24 |
| General preparation methods | Sections 5.25-5.27 |
| Quality, storage and packaging | Section 5.28 |
| Revision and examination questions | Sections 5.29-5.30 |
Learning Outcomes
- Identify ointments, pastes, creams and gels by structure, consistency and purpose.
- Compare the four classes of ointment base without confusing water absorption with drug absorption.
- Describe incorporation, levigation, fusion, emulsification and gel formation in numbered stages.
- Select excipient functions using compatibility, route, stability and drug-release considerations.
- Distinguish fatty suppository bases from bases that dissolve in body fluids.
- Calculate base requirements using a clearly defined displacement-value convention.
- Explain moulding, compression and hand rolling using labelled preparation sketches.
Essential Vocabulary
| Term | Meaning |
|---|---|
| Base | Carrier providing the bulk and physical structure |
| Levigation | Wet grinding to make a smooth particle dispersion |
| Occlusion | Barrier reducing water loss from skin |
| Emulsion | Immiscible liquid droplets in another liquid |
| Gel network | Three-dimensional structure immobilising liquid |
| Displacement | Drug occupies volume otherwise filled by base |
The central principle: Structure controls performance. A base must hold the drug uniformly, remain stable, suit the application site and permit the intended drug release. Numbered figures show formulation structure, equipment and preparation stages.
5.1 Semisolid Dosage Forms: Definitions and Classification
Semisolid dosage forms have a consistency between that of a freely flowing liquid and a rigid solid. They usually remain in place at rest but can spread when a suitable force is applied. Most preparations in this group deliver medicines locally to skin or a mucosal surface; some are designed for systemic delivery.
Diagram labels: Ointment: drug carried in a semisolid base. Paste: large solid fraction; stiff consistency. Cream: liquid droplets in a continuous phase. Gel: liquid held within a network. Structural models, not molecular-scale drawings.
Explanation: The drawings are enlarged structural models. An ointment may contain dissolved or dispersed drug, a paste has a substantial powder fraction, a cream has liquid droplets, and a gel contains a liquid held by a network.
| Form | Definition / structure | Example |
|---|---|---|
| Ointment | Semisolid base containing dissolved or dispersed ingredients | Zinc oxide ointment |
| Paste | Stiff semisolid with a large proportion of finely divided solid | Zinc oxide paste |
| Cream | Semisolid emulsion, usually O/W or W/O | Hydrocortisone cream |
| Gel | Liquid immobilised within a structured network | Carbomer gel |
- Classification by physical structure differs from classification by route. A skin ointment and an ophthalmic ointment share a dosage-form name but have different quality requirements.
- Preparations may be medicated, containing active ingredients, or unmedicated, used as protective, lubricating or formulation vehicles.
- A gel can be clear or opaque. A cream is not necessarily non-greasy: the continuous phase matters.
Why suppositories appear in this unit: Suppositories and pessaries are ordinarily solid at room temperature. Their inclusion here does not make them topical semisolids; their bases change physical state or dissolve at the administration site.
5.2 Advantages, Limitations and Performance Principles
Advantages
- Local delivery can place the medicine near the intended skin or mucosal target.
- A spreadable preparation can cover irregular surfaces and support prolonged contact.
- Bases can protect skin, reduce moisture loss or provide lubrication as well as carry a drug.
- Several base classes allow selection for dry, moist, hairy or sensitive sites.
- Suitable containers permit convenient application; unit-dose presentations can reduce repeated contamination.
Disadvantages
- An applied dose may vary with the area covered, quantity expressed and application technique.
- Greasy products may stain clothing, feel uncomfortable or be difficult to remove.
- Water-containing systems can support microbial growth and require effective control.
- Drug diffusion and partitioning can limit release; incorporation alone does not guarantee availability.
- Physical changes include separation, crystallisation, gritty aggregates, drying and viscosity changes.
- Irritation or allergy can arise from the drug, fragrance, preservative, emulsifier or another excipient.
What Determines Release?
Drug release depends on its state in the base, solubility, particle size when suspended, affinity for the base and surrounding fluid, viscosity and microstructure. A drug that strongly prefers the base may leave it slowly. Increasing apparent solubility in the base can improve uniformity yet sometimes reduce the tendency to partition into the receiving phase.
Memory trick: For performance remember SITE: Spreadability, Ingredient compatibility, Tolerability and Effective release. No single base is best for every formulation.
5.3 Ointment Bases: Ideal Properties and Selection
An ointment base supplies the carrier and physical framework of the preparation. It affects consistency, adhesion, washability, moisture balance and drug release. Base selection is a formulation decision, rather than simply a choice of colour or appearance.
- An ideal base is physically and chemically stable, compatible with the active ingredient and acceptable at the application site.
- It spreads easily, remains in useful contact, has suitable consistency and does not produce unacceptable grittiness.
- It should not cause undue irritation or sensitisation; its microbial quality must suit the route.
- It allows the intended release and is compatible with the container.
- Useful features such as washability, occlusion and water uptake depend on the clinical purpose; they are not universally desirable.
Diagram labels: Hydrocarbon: little water uptake. Absorption: accepts water; W/O. Water-removable: O/W; washable. Water-soluble: PEG carrier; dissolves in water. Water and oil/fatty phase are shown separately.
Explanation: Hydrocarbon bases exclude substantial water. Anhydrous absorption bases can take up water to form W/O systems; existing W/O absorption bases can take up additional water within their capacity. O/W bases are water-removable; PEG bases are water-soluble.
A Practical Selection Sequence
- Step 1: Identify the site, intended local or systemic action and required contact time.
- Step 2: Check drug solubility, stability and compatibility with proposed bases.
- Step 3: Decide whether occlusion, moisture uptake or easy washing is appropriate.
- Step 4: Determine how any aqueous ingredient will be incorporated.
- Step 5: Confirm release, consistency, microbial control and packaging through suitable evaluation.
Important distinction: An absorption base absorbs water. The name does not prove increased absorption of the drug through skin.
5.4 Hydrocarbon / Oleaginous Ointment Bases
Hydrocarbon bases are oily, water-insoluble materials such as white soft paraffin, yellow soft paraffin and mixtures structured with hard paraffin or related waxes. They are also called oleaginous bases in the conventional ointment-base classification.
Properties
- Generally greasy, occlusive and difficult to wash off with water.
- Provide a persistent protective film and can reduce water loss from skin.
- Take up little water without an appropriate emulsifying component.
- Anhydrous character reduces some water-related degradation risks, but does not guarantee chemical stability or freedom from contamination.
Uses and Limitations
A soft-paraffin vehicle can be useful where protection and lubrication are required. A small amount of compatible oily levigating liquid can help disperse an insoluble powder. Adding a large aqueous solution directly to an ordinary hydrocarbon base can produce poor distribution or liquid separation.
| Property | Formulation implication |
|---|---|
| Poor water washability | Removal may require an appropriate cleanser |
| Occlusive film | Useful for selected dry-skin applications |
| Little water uptake | Aqueous ingredients require a suitable alternative base |
| Strong affinity for lipophilic drug | Release must be assessed; an oily base is not automatically faster |
Memory trick: Hydrocarbon = hold a hydrophobic film. Protective and greasy, with little capacity for added water.
5.5 Absorption Ointment Bases
Absorption bases contain components that permit incorporation of water. Two subgroups must be distinguished: anhydrous bases that form W/O emulsions when water is added, and existing W/O emulsion bases that accept further water within a finite capacity.
| Subgroup | Example | Behaviour |
|---|---|---|
| Initially anhydrous | Anhydrous lanolin; hydrophilic petrolatum | Water addition produces a W/O system |
| Already contains water | Hydrous lanolin and suitable W/O bases | Can incorporate some additional water |
- Usually greasy and not readily removed with water because the external phase is oily.
- Can incorporate an aqueous drug solution in small portions while maintaining uniformity.
- The amount of water accepted depends on composition and processing; exceeding capacity can cause separation.
- Lanolin-containing systems may cause sensitivity in susceptible individuals; compatibility and tolerability still require assessment.
Water Incorporation: Preparation Sequence
- Step 1: Measure the aqueous phase required by the formula.
- Step 2: Soften or prepare the base as needed without uncontrolled heating.
- Step 3: Add the aqueous liquid in small portions with thorough mixing after each addition.
- Step 4: Inspect the emulsion for droplets, separation and uniform consistency.
- Step 5: Complete the formulation and verify stability and microbial control.
Examination distinction: Water uptake is not water washability. A W/O absorption base can accept water and still remain greasy and difficult to wash away.
5.6 Water-Removable and Water-Soluble Bases
Water-Removable Bases
These are generally oil-in-water emulsion bases. Water forms the continuous phase, so they are usually easier to remove with water and feel less greasy than hydrocarbon or W/O bases. Hydrophilic ointment is a traditional example of this class.
- They can accept compatible aqueous ingredients, but dilution can change viscosity, preservative concentration or emulsion stability.
- Water evaporation may cause drying or consistency changes. Both physical and microbial stability require control.
Water-Soluble Bases
These are commonly polyethylene glycol / macrogol (PEG) mixtures. Lower-molecular-weight grades are blended with firmer grades to obtain the desired semisolid consistency. The base is water-soluble and need not contain an oily phase.
- Usually washable and less greasy; an initially anhydrous PEG base is not an O/W emulsion.
- Adding water or another liquid may soften the base substantially. Compatibility and potential moisture withdrawal from tissues must be considered.
- Water-soluble does not mean suitable for every damaged skin surface or mucosal application.
Four-Class Comparison
| Base class | Water behaviour | Washability / feel |
|---|---|---|
| Hydrocarbon | Little uptake; insoluble | Poor; greasy |
| Absorption | Accepts water; generally W/O | Poor; usually greasy |
| Water-removable | O/W emulsion | Usually easy; less greasy |
| Water-soluble | PEG dissolves in water | Easy; generally non-greasy |
Memory trick: H-A-R-S: Hydrocarbon, Absorption, water-Removable, water-Soluble. R = emulsion; S = soluble carrier. Do not treat them as identical.
5.7 Other Excipients Used in Semisolid Preparations
Excipients perform specific jobs. An ingredient can have more than one function, but its role must be explained for the particular formulation. Concentrations are selected from an appropriate validated formula rather than transferred indiscriminately between dosage forms.
| Function | Examples | Why used |
|---|---|---|
| Emulsifier | Suitable polysorbate, sorbitan ester or emulsifying wax | Stabilises oil-water interface |
| Stiffening agent | Cetostearyl alcohol; waxes | Builds body and controls consistency |
| Humectant | Glycerol; propylene glycol | Helps retain moisture |
| Levigating liquid | Liquid paraffin; glycerol where compatible | Wets and smooths insoluble particles |
| Gelling agent | Carbomer; cellulose derivatives; poloxamer | Builds gel structure |
| Preservative | Suitable parabens or other permitted system | Controls susceptible microorganisms |
| Antioxidant | Suitable tocopherol or other antioxidant | Limits relevant oxidation |
| Chelator | Disodium edetate where appropriate | Binds selected metal ions |
| pH modifier / buffer | Compatible acid, alkali or buffer | Supports stability and gel performance |
| Solvent / co-solvent | Purified water; suitable alcohol or glycol | Dissolves selected ingredients |
- A preservative must remain effective in the phase where microorganisms can grow. Partitioning into oil, binding to polymers and adsorption can reduce the available amount.
- A humectant is not automatically a preservative. Water content and microbial risk still need evaluation.
- An antioxidant addresses oxidation; a preservative addresses microorganisms. They are not interchangeable.
- Fragrance and colouring may improve acceptability in some products but are not essential and may increase sensitivity risk.
- Penetration enhancers are formulation-specific. Their selection requires evidence of safety and performance at the intended site.
Quality distinction: Ordinary skin semisolids require suitable microbial quality. Ophthalmic ointments require sterility, suitable particle characteristics and eye-compatible ingredients; adding a preservative does not make a product sterile.
5.8 Ointments: Preparation Planning and Drug Incorporation
Ointments may contain a dissolved drug, suspended fine particles or a combination. The two principal general preparation methods are incorporation and fusion; a formulation may use both.
| Ingredient state | Suitable approach | Main concern |
|---|---|---|
| Soluble in base | Dissolve in a compatible base portion | Crystallisation on cooling or storage |
| Insoluble powder | Reduce aggregates, levigate and distribute | Grittiness and content uniformity |
| Aqueous solution | Use a base with suitable water capacity | Separation and microbial stability |
| Volatile / heat-sensitive ingredient | Add at an appropriate cooling stage | Loss or degradation |
Before Preparation
- Step 1: Verify the formula, route, total mass and ingredient identity.
- Step 2: Calculate active ingredient and base quantities, including every added liquid.
- Step 3: Select clean suitable equipment: balance, mortar and pestle, slab, spatula or mechanical mixer.
- Step 4: Choose the method according to solubility, melting behaviour and ingredient stability.
- Step 5: Plan the checks and container before starting.
Geometric Dilution
When a small quantity must be mixed into a much larger base mass, first mix it with a similar amount of base. Add another base portion approximately equal to the mixture already present, mix thoroughly and repeat until the remaining base is incorporated. The principle is progressive dilution; exact doubling is a useful teaching model rather than a requirement to weigh every increment identically.
Avoid the common error: A drug visible as small lumps is not adequately distributed. Smooth appearance is useful, but appearance alone cannot prove content uniformity.
5.9 Ointment Incorporation: Levigation and Slab Mixing
Diagram labels: Prepare powder: weigh and triturate to break aggregates. Levigate: rub with a small compatible liquid to a smooth paste. Mix progressively: add base portions; scrape and redistribute thoroughly. Check and pack: assess texture, uniformity and final mass.
Explanation: The mortar breaks aggregates, a compatible liquid produces a smooth levigated concentrate, and the spatula progressively distributes that concentrate through the base. The added liquid counts toward the final formulation mass.
- Step 1: Weigh. Weigh the drug, base and other ingredients accurately.
- Step 2: Prepare the powder. Triturate to break aggregates and obtain suitable fineness; use required particle-quality specifications.
- Step 3: Levigate. Add the minimum suitable quantity of compatible liquid and rub to a smooth paste. Liquid paraffin can suit an oleaginous system; glycerol can suit selected aqueous or hydrophilic systems.
- Step 4: Mix progressively. Incorporate a small base portion into the concentrate, then add further portions using geometric dilution.
- Step 5: Scrape and homogenise. Repeatedly collect material from the slab edges and spatula. Avoid introducing excessive air.
- Step 6: Finish. Check mass, texture and homogeneity; transfer into a suitable container with the required label.
Why Levigation Helps
Air around poorly wetted particles encourages dry clumps. A suitable levigating liquid replaces this air and permits closer contact between powder and base. It improves dispersion but does not dissolve every insoluble drug or guarantee a specific particle size.
Memory trick: W-P-L-M-C: Weigh, prepare Powder, Levigate, Mix progressively, Check. Too much levigating liquid may soften the product and change drug release.
5.10 Ointment Fusion: Controlled Melting and Cooling
Diagram labels: Inner beaker: base; outer vessel: water; stirring rod; controlled electric heat. Melt base using indirect heat and avoid overheating. Combine compatible components in a suitable order. Cool and add: mix while cooling; add sensitive ingredients suitably. Finish: check consistency and mass; fill.
Explanation: The outer vessel contains bath water; the inner beaker contains the base. Heat passes through the bath without direct flame contact with the formulation. Cooling-stage additions depend on each ingredient’s compatibility and heat stability.
- Step 1: Weigh ingredients and identify melting ranges, volatility and heat sensitivity.
- Step 2: Melt the high-melting compatible base components using controlled indirect heat.
- Step 3: Add lower-melting components in a suitable order and stir until the required uniform base is obtained.
- Step 4: Incorporate heat-stable soluble ingredients where the formula permits. Prepare insoluble ingredients separately for uniform dispersion.
- Step 5: Remove from heat and stir during cooling. Add volatile or heat-sensitive components at a suitable lower temperature.
- Step 6: Complete mixing, check consistency and mass, and fill at an appropriate stage.
Emulsion Bases Prepared by Fusion
When a base contains oil and water phases, prepare the compatible phases separately and bring them to suitable, comparable temperatures before combining as required by the emulsifier system. Continue mixing during controlled cooling. Simply pouring cold water into hot wax may cause premature solidification or separation.
Errors and Consequences
| Error | Likely consequence |
|---|---|
| Excessive heating | Drug degradation or volatile loss |
| Insufficient mixing during cooling | Uneven structure or distribution |
| Uncontrolled cooling | Crystals, lumps or inconsistent texture |
| Adding all ingredients at the start | Unnecessary exposure of sensitive materials |
Temperature principle: Use the lowest effective processing temperature and suitable time. A single fixed heating temperature cannot be applied to every ointment formula.
5.11 Pastes: Properties and General Preparation
Pastes are stiff semisolids containing a substantial proportion of finely divided insoluble solids. Traditional pharmaceutical pastes often have high powder loading, but no single percentage defines every paste. Their high solid content usually makes them less spreadable and more adherent than an ointment with a similar base.
Advantages and Limitations
- Can provide a persistent protective coating; suitable powders may absorb moisture or exudate.
- Often remain more localised and migrate less than softer ointments.
- Stiffness makes spreading and removal more difficult; pastes are often inconvenient on hairy areas.
- Poor particle preparation can cause grittiness. A stiff product is not automatically gentle or appropriate for every lesion.
Diagram labels: Prepare fine powders: break aggregates and blend evenly. Wet and incorporate: use a compatible base portion; mix progressively. Check the paste: high solids explain stiffness; inspect for grit.
Explanation: Finely divided powder is wetted and distributed before the full base quantity is added. The close-packed particles explain stiffness; the drawing does not specify a universal powder percentage.
Stepwise Preparation
- Step 1: Weigh powder ingredients and base components.
- Step 2: Triturate and mix powders; break aggregates and obtain required fineness.
- Step 3: Levigate with a small compatible liquid or a soft portion of the base, where appropriate.
- Step 4: Incorporate the remaining base progressively using thorough rubbing or suitable mixing.
- Step 5: If the base requires fusion, melt it separately under controlled conditions and incorporate powder uniformly during an appropriate cooling stage.
- Step 6: Evaluate texture, distribution and final mass; package and label.
Example: zinc oxide paste is a classic protective paste. The exact composition must be specified by the formula being studied; the name alone does not define all ingredient amounts.
Memory trick: Paste = powder-rich protection. Do not describe a paste simply as an ointment with extra water.
5.12 Creams: Emulsion Types and Preparation
Creams are semisolid emulsions. An O/W cream has oil droplets in a continuous water phase and is generally easier to wash off. A W/O cream has water droplets in a continuous oil phase and is usually more greasy and water-resistant.
| Feature | O/W cream | W/O cream |
|---|---|---|
| Continuous phase | Water | Oil |
| Typical feel | Less greasy | More greasy |
| Water removal | Usually easier | Usually more difficult |
| Representative purpose | Washable vehicle | Protective / emollient vehicle |
Diagram labels: Oil phase: compatible oils/waxes. Aqueous phase: water-soluble ingredients. Prepare phases; combine as required by the emulsifier system; cool with mixing and make suitable final additions. Emulsify, then mix while cooling. O/W and W/O sketches identify the continuous phase.
Explanation: The two beakers hold the oil and aqueous phases. Controlled combination, mixing and cooling create the semisolid emulsion. The enlarged phase sketches identify the surrounding phase rather than predicting one universal order of addition.
- Step 1: Allocate ingredients to oil phase, aqueous phase or cooling-stage additions according to solubility and stability.
- Step 2: Melt compatible waxes and oil-phase ingredients under controlled heat if required.
- Step 3: Prepare the aqueous phase separately and bring the phases to suitable comparable temperatures.
- Step 4: Combine in the order required by the emulsifier system, with effective mixing.
- Step 5: Continue controlled mixing while cooling; incorporate sensitive ingredients at suitable temperatures.
- Step 6: Compensate only for permitted process losses, complete the final mass and evaluate homogeneity, emulsion type and consistency.
- Step 7: Fill suitable containers and apply storage and route-specific labels.
Cream Stability
The emulsifier forms a stabilising interface; waxes and other structuring materials help give body. Inadequate emulsification, unsuitable pH, incompatible electrolytes or repeated temperature changes may cause separation. Emulsion type depends on the entire system, not just which phase was poured first.
Examination point: O/W and W/O describe the continuous phase. They are not alternative spellings for water-soluble and water-insoluble drugs.
5.13 Gels: Classification, Network Formation and Preparation
A gel is a structured system in which a liquid is immobilised within a three-dimensional network. The network may be formed by dispersed fine particles or by macromolecules. Gels may be aqueous (hydrogels) or contain a suitable nonaqueous liquid (organogels).
Conventional Structural Classification
- Single-phase gels: A macromolecular gelling material is distributed through the liquid without visible boundaries between separate particles; suitable carbomer and cellulose gels are examples.
- Two-phase gels: A network of small distinct particles structures the medium; bentonite magma is a conventional example.
- The term single-phase gel does not mean the polymer has disappeared. A polymer network still gives the material its structure.
Diagram labels: Disperse polymer: add gradually to avoid dry clumps. Hydrate: allow required time and processing conditions. Incorporate drug: drug + suitable vehicle; adjust pH only when the gel system requires it. Network + finish: complete quantity, reduce air and check quality. Stirring rod.
Explanation: The polymer strands are a structural model. Neutralisation is relevant to suitable carbomer formulations; it is not a compulsory step for every gelling agent. Entrapped bubbles and incomplete hydration can impair the finished appearance.
General Preparation
- Step 1: Verify the gelling-agent grade, vehicle, formula and required processing conditions.
- Step 2: Disperse the polymer gradually in the prescribed liquid to avoid clumps. Pre-wetting may be used if appropriate.
- Step 3: Allow suitable hydration or dissolution with the required temperature and mixing conditions.
- Step 4: Prepare the drug separately as a compatible solution or fine dispersion and incorporate uniformly.
- Step 5: Adjust pH or neutralise only when the particular gel system requires it. Suitable carbomers develop viscosity as ionisation permits network expansion.
- Step 6: Complete quantity, mix gently, allow or remove entrapped air, and check pH, consistency and uniformity.
- Step 7: Fill and close the container to limit contamination and loss of volatile vehicle.
Variables Affecting Gel Quality
- Polymer concentration, grade, pH, temperature and solvent composition influence gel strength.
- Electrolytes can change some networks markedly; adding a salt solution may thin or destabilise a gel.
- Syneresis is contraction of a gel network with expulsion of liquid. It differs from ordinary evaporation.
- Clear gels require appropriate solubility and processing. A suspended active ingredient can make a valid gel opaque.
Memory trick: Disperse → hydrate → incorporate → adjust when needed → finish. “Neutralise every gel” is incorrect.
5.14 Semisolid Quality, Packaging and Storage
| Attribute | What is assessed | Why important |
|---|---|---|
| Appearance / homogeneity | Colour, lumps, separation and crystals | Detects gross defects |
| Particle quality | Grittiness and relevant size distribution | Comfort and uniform distribution |
| Consistency / rheology | Flow, viscosity and response to stress | Spreading, dispensing and residence |
| Content / uniformity | Drug amount and distribution | Reliable product strength |
| pH where meaningful | Aqueous-phase or suitable measured pH | Stability and tolerability |
| Microbial quality | Appropriate microbial limits; sterility if required | Route-specific safety |
| Release / performance | Suitable in-vitro tests where applicable | Availability of the incorporated drug |
| Container performance | Closure, leakage and compatibility | Protection through storage and use |
- A rheology result is meaningful only with stated conditions such as temperature, instrument and shear setting. “Viscosity = good” without conditions is incomplete.
- A jar permits repeated contact with the bulk; a suitable tube or pump can reduce exposure. The formulation must still be compatible with the package.
- Protect from excessive heat, freezing, light or moisture as appropriate to the specific formula. Do not assign one storage temperature to all semisolids.
- The beyond-use or expiry period requires an appropriate evidence-based assessment; physical appearance alone cannot establish it.
Essential Label Information
State preparation identity, strength where applicable, quantity, intended route, directions and relevant storage instructions. A skin preparation should carry appropriate external-use wording; an ophthalmic ointment must be clearly identified for ophthalmic use. Avoid confusing products with similar-looking packs.
Correction principle: Adding more base, water or emulsifier to an unstable product is not automatically a valid repair. First identify the reason for the defect and re-evaluate the formula and process.
5.15 Semisolid Comparison and Formulation Calculations
| Feature | Ointment | Paste | Cream | Gel |
|---|---|---|---|---|
| Structure | Base with drug | High powder load | Semisolid emulsion | Liquid in network |
| Consistency | Soft to firm | Usually stiff | Spreadable | Varies with network |
| Greasy feel | Base-dependent | Base-dependent | O/W less; W/O more | Vehicle-dependent |
| Key risk | Uneven dispersion | Gritty aggregates | Phase separation | Clumps / viscosity change |
Example 1: Percentage Strength by Mass
Prepare 60 g of a 5% w/w teaching ointment using a single active ingredient and a base.
Drug mass = (5/100) × 60 = 3 g.
Base mass = 60 − 3 = 57 g.
The final quantity is 60 g, not 63 g.
Example 2: Account for Levigating Liquid
For a 50 g preparation containing 2% w/w drug and 2 g of a permitted levigating liquid:
Drug = 0.02 × 50 = 1 g.
Base = 50 − 1 − 2 = 47 g.
The levigating liquid occupies part of the total formulation mass.
Example 3: Dilution of a Concentrated Semisolid
A 10% w/w compatible preparation is diluted with unmedicated base to make 100 g at 2% w/w.
Required concentrate = (2 × 100)/10 = 20 g.
Added base = 80 g.
The calculation assumes compatible ingredients and a formulation that remains stable after dilution.
- Use mass units consistently; 500 mg = 0.5 g.
- q.s. to 100 g means add enough to reach 100 g total. It does not mean add 100 g of base.
- Mixing arithmetic does not establish emulsion stability, preservative effectiveness or clinical interchangeability.
Memory trick: Final mass = drug + every excipient + base. Account for all ingredients before calculating the remaining carrier.
5.16 Suppositories and Pessaries: Definition, Types and Shapes
Suppositories are solid single-dose preparations intended for insertion into a body cavity, particularly the rectum. The base melts, softens or dissolves at the site, releasing the active ingredient. Pessaries, in this pharmaceutical context, are vaginal dosage preparations; a solid medicated vaginal unit is also called a vaginal suppository or ovule.
Diagram labels: Rectal: torpedo/bullet-like unit. Vaginal: pessary/ovule, representative ovoid. Urethral: slender bougie, specialised route. Not to scale; mass and shape depend on the product.
Explanation: Shape is adapted to the site and mould. The units are not drawn to scale, and no universal mass or anatomical dimensions are implied. Pharmaceutical pessaries here are medicated preparations, not mechanical support devices.
| Type / site | Typical form | Possible purpose |
|---|---|---|
| Rectal suppository | Torpedo / bullet-like unit | Local or systemic delivery |
| Vaginal pessary / ovule | Ovoid or other suitable vaginal unit | Usually local therapy |
| Urethral preparation / bougie | Slender rod-like unit | Specialised local delivery |
- Rectal units can be used for local action, such as suitable laxative or anorectal preparations, or for systemic drug delivery.
- Vaginal pessaries are commonly formulated for local treatment, for example a suitable antifungal preparation.
- Unit mass depends on base density, mould capacity, formulation and intended population. Traditional adult and child mould sizes are examples, not universal specifications.
- A dosage unit must be identified by route; rectal and vaginal products are not automatically interchangeable.
Terminology caution: The word pessary can also refer to a non-medicinal mechanical vaginal support device. This unit concerns pharmaceutical vaginal preparations.
5.17 Suppositories / Pessaries: Advantages and Disadvantages
Advantages
- Offer an alternative when oral administration is unsuitable or swallowing is difficult, provided the route is clinically appropriate.
- Can provide local drug exposure at a rectal or vaginal site.
- Avoid direct contact of an orally irritant drug with the stomach when an appropriate alternative formulation exists.
- Rectal delivery may bypass part of hepatic first-pass metabolism, depending on where absorption occurs.
- A solid unit can provide a defined formulated drug quantity when manufactured and tested adequately.
Disadvantages
- Acceptance, comfort and privacy can limit use.
- Absorption can be variable because of fluid availability, placement, stool, mucosal condition and formulation properties.
- Fatty products may soften during warm storage; dissolved or softened products can leak.
- Irritation can occur from the drug, osmotic effects or excipients.
- Uneven drug distribution can arise if suspended particles settle during filling.
- Production needs suitable moulds, calibration, formulation calculations and quality control.
First-Pass Effect Explained Simply
Venous drainage from parts of the rectum reaches the portal circulation, while other drainage reaches the systemic circulation more directly. Thus rectal administration does not guarantee complete avoidance of the liver. Vaginal delivery has its own absorption conditions and should not be explained using the rectal drainage rule.
Examination correction: Write “may partly bypass hepatic first-pass metabolism”, not “always avoids first-pass metabolism completely.” Solid-unit dose accuracy also does not guarantee identical absorption in every patient.
5.18 Ideal Suppository Bases and Release Principles
A suppository base must produce a unit that is stable during storage, strong enough to handle, comfortable at the site and able to release the active ingredient appropriately. The ideal properties depend on whether the base is intended to melt or dissolve.
- Compatible with the drug and other ingredients; does not react undesirably or bind the drug so strongly that release is impaired.
- Stable on storage, with appropriate resistance to oxidation, moisture changes and structural change.
- Non-irritating at the intended site and acceptable in the quantity used.
- Solid enough for handling but able to soften, melt or dissolve as intended after insertion.
- Has suitable processing behaviour: workable melt or plastic mass, uniform filling and satisfactory removal from the mould.
- Does not allow rapid sedimentation of suspended particles during preparation.
- Has acceptable contraction and mechanical strength; excessive brittleness or deformation is undesirable.
Diagram labels: Fatty base: softens/melts to an oily phase; drug must transfer out of the carrier. Hydrophilic base: dissolves/disperses in available fluid; release also depends on drug properties. Transformation of the base is not identical to drug absorption.
Explanation: A fatty base forms a softened or melted oily phase. A hydrophilic base dissolves or disperses in available fluid. In either system the drug must leave the carrier and reach the receiving phase for release.
Partitioning Principle
A hydrophilic drug dispersed in a fatty base may favour transfer into aqueous fluid, but it must still be wetted and released. A lipophilic drug strongly soluble in the fatty base may remain there longer. A hydrophilic base can be helpful in some formulations, yet fluid availability and drug precipitation also matter. Base class alone cannot rank clinical effectiveness.
Not a universal melting requirement: Body-temperature melting applies to suitable fatty bases. PEG and glycerinated-gelatin bases principally rely on dissolution or dispersion, so the same melting rule must not be imposed on them.
5.19 Fatty Suppository Bases: Cocoa Butter and Hard Fat
Cocoa Butter / Theobroma Oil
Cocoa butter is a traditional fatty base. It is firm at ordinary cool room conditions and melts near body temperature; the exact behaviour depends on crystalline form and processing history. It is useful for fusion and suitable small-scale hand-rolling methods.
- Polymorphism means that the same chemical material can exist in different crystalline arrangements.
- Excessive heating can disrupt the desired crystal structure; subsequent cooling may produce lower-melting forms and soft units.
- Heat gently and only as far as needed. Controlled cooling and, where the process specifies, retaining suitable unmelted material can support appropriate crystallisation.
- It may require a compatible mould lubricant because contraction and mould-release behaviour are formulation-dependent.
- Drugs and additives can alter melting behaviour. Do not assume the original base properties remain unchanged.
Hard Fat / Semisynthetic Triglyceride Bases
These are processed fatty materials available in grades with defined properties. They can offer more consistent handling and release characteristics than untreated natural fat, depending on grade. Relevant specifications include melting behaviour, solidification, viscosity, hydroxyl value and compatibility.
| Property | Cocoa butter | Hard-fat grades |
|---|---|---|
| Origin | Natural triglyceride mixture | Processed / semisynthetic fatty mixture |
| Processing issue | Prominent polymorphism concern | Grade-dependent crystallisation |
| Selection | Gentle processing and compatibility | Choose specified grade for the formula |
| General release mode | Softens / melts | Softens / melts |
Avoid the overstatement: Do not claim that every hard-fat base is completely free from crystalline changes or that all grades behave identically. Select and process the actual grade.
5.20 Hydrophilic Suppository Bases: PEG and Glycerinated Gelatin
Polyethylene Glycol / Macrogol Bases
PEG bases combine grades of different molecular weights to obtain suitable hardness, processability and dissolution. They generally dissolve in available aqueous fluid rather than relying on melting at body temperature.
- Firmer grades improve mechanical strength but can change dissolution time and handling.
- Moisture attraction and osmotic effects may cause local discomfort in some formulations; tolerability is formulation-dependent.
- Check drug compatibility, solubility and release; do not treat PEG as a universal inert substitute for every fatty base.
Glycerinated Gelatin
This base contains gelatin, glycerol and water in a specified formula. It forms elastic solid units and is traditionally associated with vaginal preparations. It dissolves or disperses relatively slowly in secretions.
- Glycerol contributes humectant properties; gelatin forms the structural matrix.
- Moisture exchange can change consistency, so well-closed protective packaging is important.
- Water and gelatin make microbial control important. A suitable preservative may be needed according to the validated formulation and period of use.
- Preparation requires controlled hydration and processing of gelatin; overheating or excessive air incorporation impairs quality.
| Feature | Fatty base | PEG | Glycerinated gelatin |
|---|---|---|---|
| Main change at site | Melting / softening | Dissolution | Dissolution / dispersion |
| Moisture sensitivity | Generally low water affinity | Can attract moisture | Moisture exchange important |
| Warm-storage issue | Softening / melting | Grade-dependent stability | Formula-dependent changes |
| Key concern | Crystal form and release | Compatibility and dissolution | Microbial control and moisture |
Memory trick: Fat melts; hydrophilic bases meet fluid. The phrase identifies the main release mechanism, not a universal rate of drug absorption.
5.21 Suppository Excipients and Formulation Decisions
| Function | Examples / approach | Purpose or caution |
|---|---|---|
| Base | Cocoa butter; specified hard fat; PEG; glycerinated gelatin | Shape, stability and release |
| Surfactant / wetting agent | Suitable low-level surface-active agent | Improves wetting where needed; may irritate |
| Suspending / viscosity modifier | Compatible structuring material | Limits settling during filling |
| Antioxidant | Suitable antioxidant in oxidisable systems | Limits relevant oxidation |
| Preservative | Compatible validated preservative when required | Controls microbial growth; not universally needed |
| Plasticiser / consistency modifier | Suitable glycerol or PEG component | Adjusts flexibility and handling |
| pH modifier | Suitable buffer where relevant | Supports compatibility and tolerability |
| Mould lubricant | Compatible thin release film where needed | Assists removal; avoid excess |
Selection Sequence
Step 1: Establish site, local or systemic objective and required unit drug amount.
Step 2: Check drug solubility and compatibility in candidate bases.
Step 3: Choose melting or dissolving behaviour suited to the formulation.
Step 4: Determine mould capacity in the selected base and obtain a relevant displacement value.
Step 5: Choose processing and any necessary stabilising ingredients.
Step 6: Confirm distribution, release, mechanical properties, microbial quality and packaging.
A lubricant is a process aid, not necessarily an ingredient throughout the unit. Use only if required by the base and mould.
Use a compatible lubricant that does not dissolve or damage the formulation; excessive coating may pool at the tip and alter appearance or distribution.
Disposable shell moulds may not require lubrication. Follow the actual mould and formulation requirements.
Sedimentation control: A suspended drug can settle in a low-viscosity melt. Maintain suitable gentle mixing and fill at an appropriate viscosity without entrapping air or allowing premature setting.
5.22 Mould Calibration: Why Capacity Must Be Measured
A mould cavity fixes volume, while ingredients are usually weighed by mass. Because bases have different densities, the same cavity does not hold the same mass of every base. A nominal “2 g mould” is incomplete information without the calibration base.
Blank-Base Calibration
- Step 1: Select the intended base and use the same mould and suitable preparation method.
- Step 2: Prepare blank units containing base only. Fill the cavities consistently and allow proper setting.
- Step 3: Trim as specified, remove intact units and reject defective units from the measurement.
- Step 4: Weigh the satisfactory units and record their number.
- Step 5: Calculate average blank capacity M = total blank mass / number of units.
- Step 6: Assess reproducibility and use that capacity in drug-displacement calculations.
Example
Six satisfactory blank units weigh 12.12 g in total.
Average capacity M = 12.12 / 6 = 2.02 g of this base per cavity.
This is a mass equivalent for the selected base, not a measured cavity volume of 2.02 mL.
- Recalibrate when the base, mould or relevant process conditions change.
- Calibration units must represent the intended filling and trimming procedure.
- Do not include flash or untrimmed excess in the cavity-capacity measurement.
Memory trick: The cavity holds volume; the balance reads mass. Calibration links these two quantities for the chosen base.
5.23 Displacement Value: Definition, Convention and Formula
In these notes, displacement value f means the mass of drug that displaces 1 g of the selected base. Thus a value f = 1.5 means that 1.5 g drug occupies the cavity volume otherwise occupied by 1 g base under the specified formulation conditions.
Diagram labels: Blank unit: 2.00 g base. Loaded unit: 1.80 g base + 0.30 g drug. Same calibrated cavity volume. f = 1.5 g drug per 1 g base displaced. Base displaced = 0.30/1.5 = 0.20 g. Base remaining = 2.00 – 0.20 = 1.80 g. Loaded-unit mass = 1.80 + 0.30 = 2.10 g. Drug symbols are schematic, not scale volumes.
Explanation: Both units fill the same calibrated cavity. The loaded unit contains 0.30 g drug replacing 0.20 g base when f = 1.5. Its total mass becomes 2.10 g although the blank-base capacity is 2.00 g.
Working Equations
Let:
- n = number of units prepared.
- M = blank-base mass per cavity.
- d = drug mass per unit.
- D = n × d = total drug mass.
Base displaced = D / f
Base required = nM − D/f
Final combined mass = base required + D
- For several drugs with appropriate separate displacement values: base required = nM − (D1/f1 + D2/f2 + …), where the approximation is valid for the mixture.
- The total mass of a drug-loaded unit need not equal the blank mass, because the cavity controls volume.
- Values depend on the drug, base and relevant preparation conditions; do not transfer a value to a different base without justification.
Reciprocal Convention
Some teaching material defines a factor k as grams of base displaced by 1 g drug. That convention is the reciprocal:
k = 1/f
With k, displaced base = D × k. Read the stated definition before selecting multiplication or division.
Critical examination rule: Define the factor before calculating. Using D × f with the mass-of-drug-per-gram-base convention gives the wrong result.
5.24 Displacement Value: Worked and Experimental Calculations
Example 1: Preparing 10 Units
A mould holds 2.00 g blank base per cavity. Each unit contains 0.30 g teaching drug; f = 1.5. Prepare 10 units.
- Step 1: Blank-base requirement = 10 × 2.00 = 20.00 g.
- Step 2: Total drug D = 10 × 0.30 = 3.00 g.
- Step 3: Base displaced = 3.00 / 1.5 = 2.00 g.
- Step 4: Base required = 20.00 − 2.00 = 18.00 g.
- Step 5: Final mixture = 18.00 + 3.00 = 21.00 g; each unit contains 1.80 g base + 0.30 g drug = 2.10 g.
Example 2: Preparation Allowance
If the same exercise specifies preparation of 12 equivalent units to dispense 10, calculate both ingredients for 12:
Drug = 12 × 0.30 = 3.60 g.
Base = (12 × 2.00) − 3.60/1.5 = 21.60 g.
The extra quantity is a process allowance, not an instruction to increase the drug content of each dispensed unit.
Example 3: Experimentally Determining f
Ten blank units weigh 20.00 g. Ten correctly filled drug-loaded units weigh 21.00 g and contain a measured total of 3.00 g drug.
- Step 1: Base in loaded units = 21.00 − 3.00 = 18.00 g.
- Step 2: Base displaced = 20.00 − 18.00 = 2.00 g.
- Step 3: f = drug mass / base displaced = 3.00 / 2.00 = 1.50.
General Experimental Expression
If:
- A = blank-base mass for the same number of filled cavities.
- B = total mass of loaded units.
- D = their actual drug mass.
Then:
f = D / [A − (B − D)]
The denominator is base displaced. Accurate filling, known drug content, no significant loss and valid comparisons are necessary.
Sanity check: For f = 1.5, 0.30 g drug displaces only 0.20 g base. Same volume does not mean same mass. A negative base requirement signals an invalid calculation or an unsuitable formulation/cavity combination.
5.25 Suppositories: Fusion Moulding Step by Step
Diagram labels: Calibrate + prepare: determine capacity; calculate quantities; ready the mould. Melt + incorporate: gentle heat; distribute the drug uniformly. Fill cavities: avoid bubbles; control settling and filling viscosity. Set + release: cool suitably; trim excess, then separate the mould. Inspect + pack: check intact units and protect each unit in suitable packaging. Base; water bath; stirring rod.
Explanation: The mould is shown closed for filling and separated after setting. Each cavity must receive a uniform mixture. The trimmed unit, rather than overflow above the mould, defines the finished cavity volume.
- Step 1: Calibrate and calculate. Determine the blank-base capacity and calculate drug and base quantities using the stated displacement-value convention.
- Step 2: Prepare the mould. Clean, dry and assemble it. Apply a thin compatible lubricant only when required.
- Step 3: Prepare the drug. Obtain suitable fineness for suspended material, or prepare a compatible solution where appropriate.
- Step 4: Melt the base gently. Use suitable indirect heat and avoid unnecessary overheating; follow the selected base’s processing requirements.
- Step 5: Incorporate. Mix drug uniformly into the base. Keep a suspended ingredient distributed without excessive aeration.
- Step 6: Fill. Pour or meter the mixture into the cavities at suitable viscosity and temperature. Avoid bubbles; allow the specified excess for contraction where appropriate.
- Step 7: Set and trim. Cool under suitable conditions, remove excess at the mould surface and separate the mould without damaging it.
- Step 8: Inspect and pack. Reject defective units, perform appropriate quality checks and protect individual units in suitable packaging.
Why Filling Temperature Matters
An excessively fluid melt may allow drug sedimentation; a mixture that has begun to set can fill incompletely. The correct filling stage balances flow, distribution and controlled solidification. Rapid uncontrolled chilling can create cracks or change crystallisation.
Memory trick: C-M-D-M-I-F-S-P: Calculate, Mould ready, Drug ready, Melt, Incorporate, Fill, Set, Pack. Product-specific processing conditions take priority over a universal temperature rule.
5.26 Suppositories: Compression Moulding and Hand Rolling
Diagram labels: Compression moulding: plunger; plastic drug-base mass; shaped die; controlled pressure, no complete melting. Hand rolling: uniform cylinder divided into portions, then shaped. Both methods require calculated quantities and thorough drug distribution.
Explanation: Compression uses a plunger to force a uniform plastic mass into a shaped die. Hand rolling produces an even cylinder on a tile before division and shaping. Neither method removes the need for dose calculations or uniform mixing.
Compression Moulding
- Step 1: Calibrate the die for the base and method; calculate drug and base quantities.
- Step 2: Reduce the base to a suitable form and mix thoroughly with the drug.
- Step 3: Form a homogeneous plastic mass suitable for the equipment.
- Step 4: Load the mass and apply controlled pressure to fill the shaped die.
- Step 5: Eject, inspect and package the units after appropriate checks.
Compression avoids full melting and can help with selected heat-sensitive formulations. It needs suitable equipment and a mass with appropriate plasticity; poor loading can produce voids or unequal units.
Hand Rolling
- Step 1: Calculate quantities and triturate the fine drug with a suitable softened or grated base.
- Step 2: Knead to a uniform plastic mass using controlled handling.
- Step 3: Roll on a clean tile with a suitable board or spatula to form an even cylinder.
- Step 4: Divide accurately into the required number of portions.
- Step 5: Shape each portion appropriately, inspect and package.
Hand rolling is a traditional small-scale method associated with suitable cocoa-butter preparations. Operator skill strongly affects shape and uniformity; it is not appropriate for every base or routine large-scale production.
| Method | Main operation | Main limitation |
|---|---|---|
| Fusion | Melt, mix and cast | Heat and settling control |
| Compression | Press a plastic mass into a die | Equipment and plasticity |
| Hand rolling | Roll, divide and shape | Operator-dependent uniformity |
5.27 Pessaries: Formulation and Preparation Considerations
A pharmaceutical pessary is intended for the vaginal route. Its design must suit vaginal retention, tolerability and drug release. Ovules or moulded vaginal suppositories can be prepared using an appropriate fatty, PEG or glycerinated-gelatin base; vaginal tablets are a different formulation approach.
General Moulded-Pessary Method
- Step 1: Verify the vaginal formulation, drug amount and selected base.
- Step 2: Calibrate the mould for the actual base and calculate displaced base.
- Step 3: Prepare the base by controlled melting or the specified hydration/process method.
- Step 4: Incorporate the drug uniformly with suitable mixing.
- Step 5: Fill suitable vaginal-unit cavities, allow setting and remove or seal the units according to the presentation.
- Step 6: Evaluate identity, content, integrity, release and microbial quality; package with clear vaginal-route instructions.
Glycerinated-Gelatin Process Principles
Hydrate gelatin in the prescribed water portion, incorporate glycerol and use controlled heat and mixing to obtain the required homogeneous mass. Incorporate the drug at a suitable stage and fill while workable. The precise hydration order and processing conditions depend on the formula and gelatin grade.
- Gelatin clumps indicate incomplete wetting or hydration; vigorous stirring can trap air.
- Moisture loss may harden the preparation, while moisture uptake may soften it.
- The vaginal environment and fluid quantity influence dissolution. A local-treatment objective does not guarantee that systemic absorption is absent.
- Clear route labelling is essential; a vaginal preparation must not be presented as an oral tablet simply because it looks solid.
Examination distinction: Explain the route, base and release mechanism. Merely stating “pessaries are larger suppositories” is incomplete and can be misleading.
5.28 Suppository Quality, Defects, Packaging and Storage
| Check | Purpose |
|---|---|
| Appearance and integrity | Detect cracks, voids, leakage or malformed units |
| Mass consistency | Assess reproducibility of filling |
| Assay / content uniformity | Verify drug amount and distribution |
| Softening / disintegration / dissolution | Evaluate the relevant base transformation |
| Drug release | Assess release under suitable test conditions |
| Mechanical handling | Check adequate strength and resistance to deformation |
| Microbial quality | Meet requirements appropriate to route and formula |
| Stability / package compatibility | Maintain quality through intended storage |
Common Defects and Likely Process Causes
| Defect | Possible cause |
|---|---|
| Air cavity or bubbles | Aeration or poor filling technique |
| Uneven drug distribution | Settling, incomplete mixing or inconsistent filling |
| Cracks / brittleness | Unsuitable cooling or base composition |
| Soft or distorted units | Excessive heat exposure; unsuitable crystal form or base |
| Shrinkage hollow | Contraction without appropriate filling allowance |
| Difficult mould removal | Inadequate release properties or mould preparation |
| Moisture-related change | Insufficient protective packaging |
- Mass uniformity is useful but cannot replace drug-content evaluation: identical masses can contain unequal drug amounts.
- Protect individual units using suitable strips, shells, wraps or other validated packaging.
- Fatty units need protection from excessive warmth; hygroscopic bases need suitable moisture barriers. Refrigeration is not a universal instruction.
- State route, identity, drug strength, quantity and storage requirements clearly. Packaging should prevent confusion between rectal and vaginal products.
- Storage limits and expiry or beyond-use periods depend on the formulation and supporting evidence, not on a single general rule.
Quality link: A mould produces a shape. Formulation, controlled processing and testing produce a reliable medicine. A neatly shaped unit alone does not demonstrate correct content or release.
5.29 Quick Revision and Common Examination Errors
Semisolids in One Page
- Ointment: Drug in a semisolid base; incorporation and fusion are principal methods.
- Paste: High powder loading, stiffness and protective residence; prepare fine particles and distribute progressively.
- Cream: Semisolid emulsion; O/W is usually more washable, W/O usually more greasy.
- Gel: Liquid held in a network; prepare according to the polymer, vehicle and drug.
- Hydrocarbon: Greasy, occlusive, little water uptake.
- Absorption: Accepts water; normally oily-continuous after water uptake.
- Water-removable: O/W emulsion base.
- Water-soluble: PEG carrier.
- Levigation: Wet grinding to a smooth concentrate; then progressive base incorporation.
- Fusion: Controlled melting followed by suitable additions and mixing during cooling.
Suppositories in One Page
- Rectal suppository: Local or systemic intent; first-pass avoidance may be partial.
- Pessary: Pharmaceutical vaginal preparation; route must be explicit.
- Fatty base: Usually melts or softens at the site.
- PEG / glycerinated gelatin: Chiefly dissolves or disperses in available fluid.
- Calibration: Determine the blank-base mass in the actual cavity.
- Displacement value f: Grams drug displacing 1 g base; base displaced = D/f.
- Base required: nM − D/f.
- Methods: Fusion moulding, compression and hand rolling.
Statements to Correct
| Incorrect statement | Correct principle |
|---|---|
| All ointments are greasy | Base class determines feel |
| Absorption base means drug absorption | The name refers to water uptake |
| All gels need neutralisation | Only appropriate gel systems do |
| All suppository bases melt at body temperature | Hydrophilic bases rely on fluid dissolution |
| A 2 g blank must give a 2 g medicated unit | Equal volume can give different masses |
| Rectal delivery completely avoids first pass | Avoidance is variable and often partial |
Answer-building memory trick: Use D-C-P-M-Q: Definition, Classification, Properties, Method and Quality. Add a labelled figure where it explains the preparation or structure.
5.30 Possible Examination Questions and Numerical Practice
Short-Answer Questions
- Define ointment, paste, cream and gel with one example each.
- What is levigation? Distinguish it from trituration.
- Classify ointment bases and name one example of each class.
- Explain water absorption versus water washability.
- State the roles of humectants, emulsifiers and preservatives in semisolids.
- Define syneresis and give one formulation concern in gel preparation.
- Define suppository and pharmaceutical pessary. List the principal routes.
- What is cocoa-butter polymorphism, and why does processing matter?
- Define mould calibration and displacement value with the convention stated.
- Why does mass uniformity not establish content uniformity?
Long-Answer Questions
- Compare the four ointment-base classes with properties, examples and selection considerations.
- Describe incorporation and fusion methods of ointment preparation using labelled equipment sketches.
- Explain the formulation and numbered preparation of pastes, creams and gels.
- Discuss ideal suppository bases and compare fatty, PEG and glycerinated-gelatin systems.
- Describe fusion moulding, compression moulding and hand rolling; include quality checks and packaging.
- Explain displacement value, derive the base-requirement expression and solve a numerical example.
Numerical Practice with Answers
- 1. Calculate drug and base for 80 g of a 3% w/w ointment containing only these two components. Answer: drug = 2.40 g; base = 77.60 g.
- 2. Prepare 40 g at 1% w/w using 5% w/w concentrate and compatible unmedicated base. Answer: concentrate = 8 g; base = 32 g.
- 3. Eight cavities each hold 2.00 g blank base. Each unit needs 0.25 g drug with f = 2.0. Answer: drug = 2.00 g; displaced base = 1.00 g; base required = 15.00 g; total mixture = 17.00 g.
- 4. Blank units for the same cavities weigh 18.00 g; loaded units weigh 19.20 g and contain 2.40 g actual drug. Calculate f. Answer: loaded base = 16.80 g; displaced base = 1.20 g; f = 2.40/1.20 = 2.00.
- 5. Convert f = 4.0 to the reciprocal factor k. Answer: k = 1/4 = 0.25 g base displaced per gram drug.
A complete process answer: Show the preparation in numbered steps, label the equipment, explain why critical stages are needed, and finish with appropriate quality and packaging points.